Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo

Show other versions (1)

<h4>Background</h4> Annual mass drug administrations (MDA) of ivermectin will strongly reduce Onchocerca volvulus microfilariae (mf) in the skin and in the onchocerciasis patients’ eyes. Ivermectin treatment will also affect the expression of immunity in patients, such that activated imm...

Full description

Bibliographic Details
Main Authors: Saskia I. Johanns, Richard G. Gantin, Bawoubadi Wangala, Kossi Komlan, Wemboo A. Halatoko, Meba Banla, Potchoziou Karabou, Adrian JF Luty, Hartwig Schulz-Key, Carsten Köhler, Peter T. Soboslay
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064110/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064110/?tool=EBI

Similar Items